Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/29/2003EP1357194A2 Adapter for the connection of a biosensor to a measuring device
10/29/2003EP1357185A1 4-[(3-methyl-2(3H)-benzothiazolyliden)methylene]-quinoline and -pyridine derivatives as reporter groups in probes for analysis of nucleic acids
10/29/2003EP1357181A1 Novel atopic dermatitis-associated gene and proteins
10/29/2003EP1357126A1 Method of assaying lysophospholipase d activity
10/29/2003EP1356860A2 Quality control method of DNA microarray
10/29/2003EP1356824A2 88KDA tumorigenic growth factor and antagonists
10/29/2003EP1356412A2 A global electronic medicine response profile testing network
10/29/2003EP1356410A2 Method and apparatus for predicting a signal peptide cleavage site
10/29/2003EP1356302A2 Method and device for collecting and stabilizing a biological sample
10/29/2003EP1356300A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides
10/29/2003EP1356298A2 Diagnosis and treatment of disease
10/29/2003EP1356296A2 Rapid and sensitive detection of protein aggregation
10/29/2003EP1356294A2 Laminin alpha 4 subunit as a diagnostic indicator of malignant tumors
10/29/2003EP1356293A2 Compositions and methods involving staphylococcus aureus protein staau-r9
10/29/2003EP1356292A2 Marker for antidepressant therapy and methods related thereto
10/29/2003EP1356290A2 Method of disrupting interactions between biotin and biotin-binding compounds
10/29/2003EP1356289A2 A system for developing assays for personalized medicine
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356287A2 Replication assay for detecting anti-viral substances
10/29/2003EP1356286A2 Method for estimating metabolic function of xenobiotic and induction thereof
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356280A2 Tissue-based water quality biosensors for detecting chemical warfare agents
10/29/2003EP1356279A2 Water-soluble, fluorescent, & electrophoretically mobile peptidic substrates for enzymatic reactions and methods for their use in high-throughput screening assays
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356277A2 Method for altering cell fate
10/29/2003EP1356276A2 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action
10/29/2003EP1356269A2 Thick film conductor composition for use in biosensors
10/29/2003EP1356124A2 Circulating epstein-barr virus dna in the serum of patients with gastric carcinoma
10/29/2003EP1356123A2 A quantitative assay for nucleic acids
10/29/2003EP1356122A2 Ammonium sulfate for neutralization of inhibitory effects
10/29/2003EP1356120A2 Arrayed polynucleotides and their use in genome analysis
10/29/2003EP1356119A2 The preparation of polynucleotide arrays
10/29/2003EP1356118A2 Method for non-redundant library construction
10/29/2003EP1356117A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof
10/29/2003EP1356116A2 Hybridization buffers using low molecular weight dextran sulfate and methods for their use
10/29/2003EP1356115A1 Methods for detection of chloral hydrate in dichloroacetic acid
10/29/2003EP1356114A2 Brain tumor diagnosis and outcome prediction
10/29/2003EP1356113A2 Methods for determining organisms
10/29/2003EP1356112A2 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat
10/29/2003EP1356111A2 Nucleus export reporter system
10/29/2003EP1356110A2 Non-invasive method for detecting target rna
10/29/2003EP1356109A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
10/29/2003EP1356108A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356107A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356106A2 Method for determining skin stress or skin ageing in vitro
10/29/2003EP1356104A2 Methods and probes for detection and/or quantification of nucleic acid sequences
10/29/2003EP1356103A2 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample
10/29/2003EP1356102A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
10/29/2003EP1356101A2 Gene discovery using microarrays
10/29/2003EP1356100A2 Method for the characterization and/or identification of genomes
10/29/2003EP1356099A2 Method and nucleic acids for the analysis of astrocytomas
10/29/2003EP1356098A2 Method for determining a partial nucleotide sequence of a nucleic acid molecule
10/29/2003EP1356097A2 The anti-neoplastic agent et-743 inhibits trans activation by sxr
10/29/2003EP1356096A2 Method for identification, separation and quantitative measurement of nucleic acid fragments
10/29/2003EP1356095A2 Method for identifying metastatic tumor cells
10/29/2003EP1356094A2 Methods and compositions for transcription-based nucleic acid amplification
10/29/2003EP1356093A2 Gene markers for lung cancer
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356091A2 Method of detecting inflammatory lung disorders
10/29/2003EP1356090A2 Sequence based screening
10/29/2003EP1356089A2 Association of dopamine beta-hydroxylase polymorphisms with bipolar disorder
10/29/2003EP1356088A2 Compositions and methods for array-based nucleic acid hybridization
10/29/2003EP1356087A2 Genetic determinant for chronic inflammatory disease
10/29/2003EP1356086A2 Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular dna
10/29/2003EP1356085A2 Identification of modulators of dham-kinase and inflammatory diseases
10/29/2003EP1356084A2 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
10/29/2003EP1356083A2 Methods and compositions for glycosidase assays
10/29/2003EP1356082A2 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
10/29/2003EP1356081A2 Method and device for detecting bacterial contamination
10/29/2003EP1356080A1 Detection and identification of groups of bacteria
10/29/2003EP1356079A2 Srebp pathway modulation through targeting hisrs
10/29/2003EP1356078A2 Methods for diagnosing and treating pediatric neoplasms
10/29/2003EP1356077A2 An electronic database of enzyme substrate and enzyme inhibitor structures
10/29/2003EP1356061A2 Artificial transcriptional factors and methods of use
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356051A2 Genes
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/29/2003EP1356040A2 14189, a novel human kinase and uses thereof
10/29/2003EP1356039A2 Down syndrome critical region 1-like 1 proteins
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356030A1 Runx3 gene showing anti-tumor activity and use thereof
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356025A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355950A1 Antibodies for human cytochrome p450 2d6
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355934A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355933A2 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative diseases
10/29/2003EP1355932A2 Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells
10/29/2003EP1355931A2 Methods for monitoring multiple gene expression
10/29/2003EP1355930A2 A method for identification, isolation and production of antigens to a specific pathogen
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/29/2003EP1355924A2 Armed peptides
10/29/2003EP1355917A2 Compositions and methods relating to breast specific genes and proteins
1 ... 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 ... 3003